Brief: Tempest Expects To Have Sufficient Resources To Fund Operations Through Q2 Of 2024
22/03/2023 21:33
March 22 (Reuters) - Tempest Therapeutics Inc TPST.O :
* TEMPEST REPORTS YEAR END 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
* TEMPEST THERAPEUTICS INC - TEMPEST EXPECTS TO HAVE
SUFFICIENT
RESOURCES TO FUND OPERATIONS THROUGH Q2 OF 2024
Source text for Eikon: ID:nGNX82QwQj
Further company coverage: TPST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempest Therapeutics
See all newsBrief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
Tempest Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempest Therapeutics - Enters $50 Million Common Stock Purchase Agreement With Lincoln Park
Tempest Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Tempest Announces Development Collaboration With Senlang Biotechnology For TPST-4003, A CD7-Targeted Next-Generation In Vivo CAR-T